To determine the significance of systemic RANKL inhibition for male reproduction, conducting
a clinical controlled randomized double blinded intervention study on infertile men, to
investigating whether Denosumab (Prolia) can increase semen quality and to investigate what
subgroup of infertile men that might benefit from treatment.